Assessment of Obesity, Dyslipidemia, Hyperglycemia, and Pro-Inflammatory Cytokines as Cardiovascular Disease Risk Factors in Acromegaly Patients
Cardiovascular disease is one of the most common comorbidities associated with enlarged extremities, occurring in 60 % of patients with acromegaly. The aim of this study is to evaluate the relationship of growth hormone and insulin such as growth factor-1 with obesity, dyslipidemia, hyperglycemia,...
Main Authors: | Noor Thair. Tahir, Sura A. Abdulsattar, Fatin F. Alkazzaz |
---|---|
Format: | Article |
Language: | Arabic |
Published: |
College of Science for Women, University of Baghdad
2022-10-01
|
Series: | Baghdad Science Journal |
Subjects: | |
Online Access: | https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/6002 |
Similar Items
-
Leptin Level in Newly Diagnosed Iraqi Acromegaly Patients
by: Noor Thair Tahir
Published: (2018-03-01) -
Early postoperative measurement of growth hormone level for prognosis of surgical outcomes in acromegaly
by: A. I. Tsiberkin, et al.
Published: (2020-11-01) -
Acromegaly and hypertension
by: WANG Shu-chang, ZHU Hui-juan, PAN Hui
Published: (2021-09-01) -
Characteristics and treatment outcomes of micromegaly – acromegaly with apparently normal basal GH: A retrospective study and literature review
by: Inacio Isabel, et al.
Published: (2022-04-01) -
Impairment in insulin secretion without changes in insulin resistance explains hyperglycemia in patients with acromegaly treated with pasireotide LAR
by: Peter Wolf, et al.
Published: (2022-11-01)